US HB8267 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 7 2024 - 25% progression
Action: 2024-05-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 7 2024 - 25% progression
Action: 2024-05-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.
Title
Old Drugs, New Cures Act
Sponsors
| Rep. Donald Davis [D-NC] | Rep. August Pfluger [R-TX] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-10 | House | Referred to the Subcommittee on Health. |
| 2024-05-07 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2024-05-07 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/8267/all-info |
| Text | https://www.congress.gov/118/bills/hr8267/BILLS-118hr8267ih.pdf |
